Nonmedical use of tapentadol immediate release by college students

Clinical Journal of Pain

Volumn 30, Issue 8, 2014, Pages 685-692

  Dart, Richard C ^a,b   Bartelson, Becki B ^a   Adams, Edgar H ^c  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Labcorp Drug Development   (United States)

Author keywords

college students; nonmedical use; opioids; RADARS system; tapentadol

Indexed keywords

BUPRENORPHINE; CANNABIS; FENTANYL; HYDROCODONE; HYDROMORPHONE; ILLICIT DRUG; METHADONE; MORPHINE; OXYCODONE; PSYCHEDELIC AGENT; TAPENTADOL; TRAMADOL; NARCOTIC ANALGESIC AGENT; PHENOL DERIVATIVE; PRESCRIPTION DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COLLEGE STUDENT; DRUG ABUSE; FEMALE; HUMAN; INHALATION; INJECTION; MALE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; TOBACCO USE; ADOLESCENT; PAIN; PSYCHOLOGY; QUESTIONNAIRE; RETROSPECTIVE STUDY; STUDENT; UNITED STATES; UNIVERSITY; YOUNG ADULT;

ADOLESCENT; ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; PAIN; PHENOLS; PRESCRIPTION DRUGS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STUDENTS; UNITED STATES; UNIVERSITIES; YOUNG ADULT;

EID: 84904071265     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0000000000000001     Document Type: Article

References (30)

1. Catalano RF, White HR, Fleming CB, et al. Is nonmedical prescription opiate use a unique form of illicit drug use? Addict Behav. 2011;36:79-86.
2. Substance Abuse and Mental Health Services Administration. Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings (NSDUH Series H-41A, HHS Publication No. SMA 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. Available at: http://www.samhsa.gov/data/NSDUH/ 2k10Results/Web/HTML/2k10Results.htm. Accessed April 18, 2012; 2011.
3. Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30:300-305.
4. Inciardi JA, Surratt HL, Cicero TJ, et al. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 2009;10:537-548.
5. McCabe SE, Teter CJ, Boyd CJ. Illicit use of prescription pain medication among college students. Drug Alcohol Depend. 2005;77:37-47.
6. McCabe SE. Screening for drug abuse among medical and nonmedical users of prescription drugs in a probability sample of college students. Arch Pediatr Adolesc Med. 2008;162:225-231.
7. McCabe SE, Boyd CJ, Cranford JA, et al. A modified version of the Drug Abuse Screening Test among undergraduate students. J Subst Abuse Treat. 2006;31:297-303.
8. McCabe SE, West BT, Wechsler H. Trends and college-level characteristics associated with the non-medical use of prescription drugs among US college students from 1993 to 2001. Addiction. 2007;102:455-465.
9. RADARSs System homepage, 2011. Available at: http:// www.radars.org/. Accessed December 7, 2011.
10. Tzschentke TM, Christoph T, Kö gel B, et al. -(1R,2R)-3-(3- Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel m-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther. 2007;323: 265-276.
11. Daniels S, Casson E, Stegmann JU, et al. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin. 2009;25:1551-1561.
12. Daniels SE, Upmalis D, Okamoto A, et al. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr Med Res Opin. 2009;25:765-776.
13. Hartrick C, Van Hove I, Stegmann J-U, et al. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active-and placebo-controlled study. Clin Ther. 2009;31:260-271.
14. Hale M, Upmalis D, Okamoto A, et al. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study. Curr Med Res Opin. 2009;25:1095-1104.
15. Nucynta. Nucyntas (Tapentadol) Immediate-Release Oral Tablets [package insert]. Raritan, NJ: Ortho-McNeil-Janssen Pharmaceuticals Inc.; 2011; 2011.
16. Palexia. Palexias (Tapentadol) Oral Film-Coated Tablets [summary of product characteristics]. Aachen, Germany: Grü nenthal GmbH; 2011; 2011.
17. Substance Abuse and Mental Health Sevices Administration. Results From the 2011 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
18. Dart RC, Surratt H, Cicero T, et al. Tapentadol immediate release abuse: the first 24 months. J Opioid Manag. 2012;8:395-402.
19. Skinner HA. The drug abuse screening test. Addict Behav. 1982;7:363-371.
20. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future National Survey Results on Drug Use, 1975-2004: Vol. II. College Students and Adults Ages 19-45. Bethesda, MD: National Institute on Drug Abuse (NIH publication 05-5728) 2005. Available at: http://www.monitoringthefuture.org/ pubs/ monographs/vol2-2004.pdf. Accessed December 7, 2011; 2005.
21. Mohler-Kuo M, Lee JE, Wechsler H. Trends in marijuana and other illicit drug use among college students: results from 4 Harvard School of Public Health College Alcohol Study surveys: 1993-2001. J Am Coll Health. 2003;52:17-24.
22. Substance Abuse and Mental Health Services Administration. Results From the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586 Findings). Rockville, MD: Substance Abuse and Mental Health Services Administration. Available at: http:// www.oas.samhsa.gov/NSDUH/2k9NSDUH/ 2k9ResultsP.pdf. Accessed December 7, 2011; 2010.
23. McCabe SE, Morales M, Cranford JA, et al. Race/ethnicity and gender differences in drug use and abuse among college students. J Ethn Subst Abuse. 2007;6:75-95.
24. Aud S, Hussar W, Kena G, et al. The Condition of Education 2011 (NCES 2011-033). US Department of Education, National Center for Education Statistics. Washington, DC: US Government Printing Office. Available at: http://nces.ed.gov/pubs2011/ 2011033.pdf. Accessed September 9, 2013.
25. National Center for Education Statistics. Out of the lecture hall and into the classroom: 1992-93 college graduates and elementary/secondary teaching. NCES 96-899; 1996. Available at: http://nces.ed.gov/pubs/web/96899.asp. Accessed September 9, 2013.
26. National Center for Education Statistics. Projections of education statistics to 2020. NCES 2011-026; 2011. Available at: http://nces.ed.gov/ programs/projections/projections2020/ tables/table-21ct.asp. Accessed April 18, 2012.
27. Smith M, Rosenblum A, Parrino M, et al. Validity of selfreported misuse of prescription opioid analgesics. Subst Use Misuse. 2010;45:1509-1524.
28. Darke S, Heather N, Hall W, et al. Estimating drug consumption in opioid users: reliability and validity of a "recent use" episodes method. Br J Addict. 1991;86:1311-1316.
29. Langendam MW, van Haastrecht HJ, van Ameijden EJ. The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities. Int J Epidemiol. 1999;28: 514-520.
30. Edwards PJ, Roberts I, Clarke MJ, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009;8:MR000008.